Fosdenopterin

N/A

Report date: 2024/04/17 16:33:10
NMEFirst In Class

Base Information

Drug NameFosdenopterin
Drug Alias NamePrecursor ZcPMP-cpdcPMPCyclic pyranopterin monophosphateNULIBRY +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMolybdenum cofactor stimulants
TargetsMolybdenum cofactor
Therapy Area/IndicationsMolybdenum cofactor deficiency (MoCD)Metal Metabolism, Inborn Errors
Global Approved IndicationsMolybdenum cofactor deficiency (MoCD)Metal Metabolism, Inborn Errors
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2021/02/26
Country/TerritoryUnited StatesNetherlandsTunisia +[10] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOrigin Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedison PharmaSentynl Therapeutics IncOrigin Biosciences Inc +[6] 
Inactive CompaniesOrphatech Pharmaceuticals Gmbh
Active IndicationsMolybdenum cofactor deficiency (MoCD)Metal Metabolism, Inborn Errors
Inactive IndicationsN/A

Other Information

ATC CodeA16AX
Related LinksWikipediaDrugBankKEGG